These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 20133020)
1. [Experience with 123I-Iodobenzamide in the differential diagnosis of Parkinson's disease and Parkinson-plus disease]. Paniagua Correa C; García Alonso P; Balsa Bretón MA; Mariana Monguía A; Penín González FJ; Pey Illera C Rev Esp Med Nucl; 2010; 29(2):57-62. PubMed ID: 20133020 [TBL] [Abstract][Full Text] [Related]
2. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes. Hierholzer J; Cordes M; Venz S; Schelosky L; Harisch C; Richter W; Keske U; Hosten N; Mäurer J; Poewe W; Felix R J Nucl Med; 1998 Jun; 39(6):954-60. PubMed ID: 9627325 [TBL] [Abstract][Full Text] [Related]
7. [The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test]. Hierholzer J; Cordes M; Schelosky L; Sander B; Böck JC; David I; Horowski R; Poewe W Rofo; 1993 Jul; 159(1):86-90. PubMed ID: 8334264 [TBL] [Abstract][Full Text] [Related]
8. Cortical and subcortical patterns of I-123 iodobenzamide SPECT in striatal D(2) receptor parkinsonisms. Pifarré P; Cuberas G; Hernández J; Lorenzo C; Miquel F; Castell-Conesa J Clin Nucl Med; 2010 Apr; 35(4):228-33. PubMed ID: 20305408 [TBL] [Abstract][Full Text] [Related]
9. Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT. Schelosky L; Hierholzer J; Wissel J; Cordes M; Poewe W Mov Disord; 1993 Oct; 8(4):453-8. PubMed ID: 8232354 [TBL] [Abstract][Full Text] [Related]
10. 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism. Schwarz J; Tatsch K; Arnold G; Ott M; Trenkwalder C; Kirsch CM; Oertel WH Neurology; 1993 Dec; 43(12 Suppl 6):S17-20. PubMed ID: 8264906 [TBL] [Abstract][Full Text] [Related]
11. 123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia. Berding G; Gratz KF; Kolbe H; Meyer GJ; Dengler R; Knoop BO; Hundeshagen H Nuklearmedizin; 1994 Oct; 33(5):194-9. PubMed ID: 7997377 [TBL] [Abstract][Full Text] [Related]
12. [Cerebral SPECT with iodine-123 IBZM in patients with extrapyramidal system disorders: the evaluation of its sensitivity in therapy with dopaminergic drugs]. Hierholzer J; Castelli L; Cordes M; Schelosky L; Poewe W; Felix R Radiol Med; 1996 Mar; 91(3):207-10. PubMed ID: 8628932 [TBL] [Abstract][Full Text] [Related]
13. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease. Seppi K; Schocke MF; Donnemiller E; Esterhammer R; Kremser C; Scherfler C; Diem A; Jaschke W; Wenning GK; Poewe W Mov Disord; 2004 Dec; 19(12):1438-45. PubMed ID: 15390073 [TBL] [Abstract][Full Text] [Related]